Sadik Esener, Ph.D., Director, OHSU Knight Cancer Institute Center for Early Detection Research. (OHSU)

Dhanir Tailor, Ph.D., left, Sanjay Malhotra, Ph.D., and Arpit Dheeraj, Ph.D., are among the developers of the first drug that targets YB-1, an important signaling point in many different cancers. The drug has shown powerful anti-tumor activity in animal models of several different tumor types. (OHSU/Christine Torres Hicks)

OHSU thoracic radiologist Chara Rydzak, M.D., Ph.D., helps people get screened for lung cancer using a low-dose CT scanner. She is one of the medical co-directors of OHSU’s new lung cancer screening program. (OHSU/Chris Lydgate)

OHSU thoracic radiologist Chara Rydzak, M.D., Ph.D., helps people get screened for lung cancer using a low-dose CT scanner. She is one of the medical co-directors of OHSU’s new lung cancer screening program. (OHSU/Chris Lydgate)

OHSU thoracic radiologist Chara Rydzak, M.D., Ph.D., helps people get screened for lung cancer using a low-dose CT scanner. She is one of the medical co-directors of OHSU’s new lung cancer screening program. (OHSU/Chris Lydgate)

Family doctors like Katie Putnam, M.D., M.P.H., play a critical role in helping patients who smoke understand the benefits and risks of getting screened for lung cancer. Putnam is one of the medical co-directors of OHSU’s new lung cancer screening program. (OHSU/Chris Lydgate)